Skip to main content

Spain To Quadruple Legal Medical Cannabis Production This Year

Late last month lawmakers in Spain considered a cannabis reform measure, and while the measure did not pass, Spain’s emerging legal cannabis industry will undergo a fairly substantial expansion this year regardless. The Spanish Medicines Agency recently notified the International Narcotics Control Board that it plans to (roughly) quadruple the amount of legal medical cannabis grown within its borders.

As verified by Público, Spain’s Ministry of Health “has forecast a production of 23.43 tons of medical cannabis in Spain this year.” As required by international agreements, Spain has to notify the International Narcotics Board of the United Nations every year regarding how much domestic medical cannabis it projects it will produce. This year’s notification from Spain is obviously a considerable increase compared to last year.

Why It’s Not Enough

For some historical context, consider that in 2019 and 2020 Spain reported to the International Narcotics Board that it would cultivate 500 kilos each year. That figure increased in 2021 to a reported 600 kilos. The following year in 2020 the figure grew exponentially to a reported 6,000 kilos. This year’s reported forecast of 23.43 tons compared to just two years ago highlights how fast Spain’s medical cannabis industry is expanding. And yet, it’s not enough. Not even close.

The boost in cannabis production in Spain will benefit exports and research, however, it’s not going to help Spain’s regulated domestic medical cannabis industry being that Spain doesn’t really have one, at least not compared to many other nations. As pointed out by Público, only two medical cannabis pharmaceutical products are authorized in Spain right now (Sativex and Epidiolex).

As such, most patients rely on the unregulated market to source their medical cannabis products, including from unregulated clubs that operate in a ‘grey area’ of the law. Spain doesn’t just need a boost in domestic medical cannabis production – it also needs to reform its laws to embrace and develop the domestic medical cannabis industry in a way that helps as many patients as possible.

A Boost For Reform Efforts

Increasing domestic medical cannabis production in Spain is generally a good thing. If it helps suffering patients abroad via direct access to medical cannabis, that is still beneficial, and if it contributes to groundbreaking research that helps suffering patients around the world, that is also beneficial. With that being said, clearly, there is still a lot more that can and should be done.

Fortunately, Spain is about to receive a boost for reform efforts via the world’s largest cannabis super-event that starts later this week. On March 9th policymakers, industry leaders, and cannabis advocates from all over the globe will descend on Barcelona, first for the International Cannabis Business Conference (March 9th), and then for Spannabis (March 10th-12th). A limited number of tickets are still available for both events.

The two events have once again teamed up to create an opportunity for thought leaders from around the world to discuss cannabis policy inside and outside of Spain. Whenever the world’s smartest cannabis brains get together amazing things happen, and this month in Barcelona will be no exception.

India Is Working To Legalize Industrial Medical Cannabis Cultivation

India has one of the oldest connections to cannabis out of any nation on earth, particularly for sacramental purposes. According to Psychology Today, “The earliest mention of cannabis has been found in The Vedas, or sacred Hindu texts. These writings may have been compiled as early as 2000 to 1400 B.C.”

A common form of cannabis in India is bhang, which is a drink infused with various levels and types of cannabis. Bhang is reportedly common in many parts of India, even though it is technically illegal.

According to section 20 of India’s Narcotic Drugs and Psychotropic Substances Act (1985), ‘the sale/purchase, transportation, interstate import/export or any other commercial activity of cannabis’ is a punishable offense.

Cannabis use is largely tolerated in India, although there are definitely instances of people receiving harsh punishments for simple possession. Medical cannabis use is legal to some degree, with the Centre telling the Delhi High Court in January 2022 that the use of cannabis is ‘not completely banned’ and that ‘medical and scientific use of cannabis is allowed under the law.’

Uttarakhand became the first state in India to allow commercial cultivation of hemp crops back in 2018, and in 2019 the Madhya Pradesh government followed suit. In February 2020 India permitted its first medical cannabis clinic to open in Bengaluru.

Yet, large-scale cultivation of medical cannabis nationwide has remained out of reach. That could be changing soon. Per The Tribune:

Chief Parliamentary Secretary (CPS) Sunder Singh Thakur said today that the state government was working to legalise the cultivation of cannabis for medicinal and industrial purposes. The government would formulate a policy for cannabis cultivation so that farmers could get additional income, he added.

He presided over the inaugural ceremony of the three-day training workshop of the Himalayan Forest Research Institute (HFRI), Shimla, at the Atal Bihari Vajpayee Institute of Mountaineering and Allied Sports, Manali.

How long it will take for such reforms to be fully implemented is unclear at this time. What is clear is that if India succeeds in its pursuits, it will move closer to taking its rightful spot as an international cannabis industry powerhouse.

Uruguay’s Medical Cannabis Industry To Expand Via Authorization Of ‘Master Formulas’

Uruguay was the first country to ever pass and implement a national adult-use legalization measure. Lawmakers initially passed a legalization measure back in 2013, and regulated adult-use sales via pharmacies began in 2017.

Since that time Uruguay’s emerging legal adult-use industry has garnered significant international attention and generated considerable headlines, and rightfully so. After all, what Uruguay did and continues to do on the adult-use front is truly historic.

However, Uruguay’s cannabis industry and policy are not limited to just adult-use cannabis. Uruguay’s medical cannabis program, which receives far less attention, is set to undergo a fairly substantial expansion thanks to a recent authorization by the government. Per Montevideo (translated to English):

The government established through a decree the expansion of access routes to products made from medical cannabis, by regulating a procedure to be able to carry out treatments through master formulations prescribed by treating doctors and made in authorized pharmacies.

The decree enabled access to “master preparations based on cannabis extracts or standardized cannabinoids, from companies authorized by the Department of Medicines for the production of plant raw material with pharmacological activity.” “These master preparations may exclusively contain active principles derived from cannabis,” added the second article of the regulations.

This new authorization will hopefully help some of the most suffering patients in the South American nation, who historically have had to rely on less-sophisticated forms of medical cannabis. This is not to say that raw flower and rudimentary preparations are not sufficient, as those options can clearly help many people. Yet, for some suffering patients, they are not the best option.

Depending on a suffering patient’s condition(s), certain consumption methods are not as viable as others. Additionally, particular conditions and individual cases respond better to certain formulations for various reasons, so patients in Uruguay having more options to consider is a great thing from that perspective.

Cannabis Consumers In Canada Continue To Transition To The Regulated Market

Canada was the second nation to pass a national adult-use legalization measure back in 2018, with only Uruguay preceding Canada in doing so (2013). Yet, unlike Uruguay, Canada allows legal sales to anyone of legal age whereas Uruguay limits it to residents only.

As such, Canada provides the best example for international observers to monitor and see what is working with the nation’s regulated industry and what is not working. With other nations considering legalization, any insight Canada can provide is valuable.

One of the biggest measures of success for legalization is whether or not consumers transition away from the unregulated market into the regulated market. According to a recent study in Canada, that is exactly what is occurring, and at an increasing rate. Below is more information about it via a news release from NORML:

Waterloo, Canada: Canadian cannabis consumers are steadily transitioning from the unregulated market to the legal market, according to data published in the Harm Reduction Journal.

Investigators affiliated with the University of Waterloo, School of Public Health surveyed over 15,000 cannabis consumers regarding where they obtained their products. Researchers evaluated data for the years 2019 to 2021. (Canada instituted licensed retail sales of cannabis products in October 2018.)

Authors reported that the percentage of respondents legally sourcing their cannabis products increased year over year. Respondents were most likely to purchase cannabis-infused drinks, oils, and capsules from the legal marketplace. About 55 percent of respondents said they obtained cannabis flower exclusively from legally licensed retailers.

In 2019, fewer than half of consumers acknowledged obtaining their cannabis products from legal sources. According to separate consumer survey data published last year, that percentage rose to nearly 70 percent in 2020.

“Legal sourcing of cannabis was greater in 2021 than 2020 for all ten cannabis products [surveyed]. In 2021, the percentage of consumers sourcing all their products legally in the past 12 months ranged from 49 percent of solid concentrate consumers in 2021 to 82 percent of cannabis drink consumers,” investigators reported. “Transitioning consumers of all cannabis products into the regulated market is important for public health and safety. Future studies should continue to examine cannabis product sourcing in Canada over time, as well as ways to displace the illegal market for all cannabis products without also promoting the use of high-potency cannabis products.”

Full text of the study, “Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: A repeat cross-sectional study,” appears in the Harm Reduction Journal.

Bavaria’s Health Minister Is Clearly Wrong About Cannabis

I have never traveled to Bavaria, or Europe for that matter. I plan on making my first trip later this year to attend the International Cannabis Business Conference in Berlin in June. While I am excited to explore many parts of Germany, one jurisdiction that I plan on steering clear of is Bavaria. That is born out of fear, perhaps an irrational fear, regarding the German state’s reported position on cannabis, as expressed in a recent legal opinion published by Bavaria’s Health Minister Klaus Holetschek (CSU).

Obviously, there are many things that I know nothing about when it comes to Germany being that I have never traveled there, however, it is abundantly clear that Bavaria’s Health Minister despises all things cannabis. After all, various federal lawmakers in Germany are pursuing adult-use legalization as part of a governing coalition agreement and Minister Holetschek is leading the internal opposition against it.

Unfortunately for Minister Holetschek, the facts do not support his recently published ‘legal opinion,’ which I personally feel would be better described as a political hit job attempt. I have never traveled to Bavaria, but I have studied cannabis policy for multiple decades, have served on the front lines of cannabis activism for many years, and was at one point a scholarship law student. With that in mind, below are some of my thoughts and analysis regarding Minister Holetschek’s stated opinions (Minister Holetschek’s stated opinions are translated from German to English).

International And European Agreements

Many of Holetschek’s arguments seem to be based on a lack of evidence to the contrary and/or incomplete information, which are classic prohibitionist political communication tactics. Those strategies worked for a long time being that prohibition was the absolute law of the world for many years. Yet, we no longer operate in a world in which there are no examples of national-level legalization already in existence. According to Minister Holetschek, ‘above all’ the main reason why Germany should not pass an adult-use legalization measure is that it “violates international law and European law.”

“The UN drug control bodies rate a comprehensive cannabis legalization of the kind planned by the federal government in constant decision-making practice as a breach of the UN Convention on Drugs.” Minister Holetschek reportedly stated.

What Minister Holetschek fails to acknowledge in his assertion is that nothing meaningful has happened to Canada, which legalized cannabis for adult use in 2018, after Canada did quite literally what the Minister is selectively clutching his pearls about. Furthermore, the United States has allowed state-level legalization to proceed, which in itself puts the U.S. out of compliance to some degree, and nothing meaningful has happened to the U.S. federal government either. It is my understanding that both nations receive annual warnings from the UN about being out of compliance, but that is the extent of it.

It’s a safe bet that the same will prove to be true in Germany. Even if some international or continental feathers get ruffled by Germany proceeding with legalization, if history is a guide there will be nothing more than some sternly worded letters being received. Additionally, it’s absolutely worth noting that Germany’s Health Minister’s opinion regarding the EU-level component of treaties directly contradicts that of the Bavarian Health Minister, with German Health Minister Karl Lauterbach previously expressing that he was ‘certain’ that the European Union would allow Germany to proceed. People can form their own opinion, although I am going to personally rely on the opinion of the federal health minister on this one.

Protecting Youth

Minister Holetschek’s arguments regarding veiled ‘doomsday scenarios’ about youth consumption are particularly outdated.

“I cannot understand how the release of cannabis for ‘pleasure purposes’ for young people over the age of 18 should improve health and youth protection.” Minister Holetschek reportedly stated. That statement is like something straight out of the 1930s film Reefer Madness.

‘What about the children?’ is one of the most historically popular talking points used by cannabis prohibitionists. But unlike decades past, there are now many peer-reviewed studies regarding cannabis, and a growing body of pre and post-legalization public health data that can be easily acquired and examined, including data that pertains to youth consumption.

Per government data from the Oregon Health Authority, not only was there no spike in youth consumption following the launch of legal adult-use sales and outright possession legalization in 2015; youth consumption rates actually went down from 2012 to 2018 in Oregon. A broader study conducted by researchers at Michigan State University, which involved consumption survey data from over 800,000 respondents in states where cannabis sales were permitted, also found no spike in youth cannabis usage rates.

A study in 2021 conducted by researchers in Canada found ‘no significant differences’ in cannabis consumption rates before and after cannabis legalization in Canada. As of May 2022, data out of Uruguay also demonstrated no sustained changes in youth consumption rates post-legalization. If Minister Holetschek is truly worried about the youth in a post-legalized Germany, he can look at the available data and hopefully sleep better knowing that his fears are unfounded.

Public Health

“Let me be clear: I firmly oppose cannabis legalization because of the serious health risks of this drug.” Minister Holetschek reportedly stated. “Legalizing cannabis and insisting on prevention is like starting a fire and then calling the fire brigade. The Berlin traffic light coalition can’t be serious about that.”

Those statements by the minister operate on the false assumption that if cannabis is prohibited no one will consume it. To use the minister’s own wording, the fire was started a long time ago and burns at all times regardless of whether prohibition is in place or not. There is zero evidence in Germany or anywhere around the world that cannabis prohibition lowers consumption rates. From the pure consumption standpoint, the real major difference between legalization and prohibition is that people are consuming tested and regulated products in the former scenario, and consuming untested products in the latter scenario. Clearly, people consuming tested products is far superior for public health outcomes compared to forcing all consumers towards unregulated sources.

“Experiences from the USA and Canada show that the black market cannot be dried up with legalization. Rather, the black market continues to exist.” Minister Holetschek also reportedly stated.

Again, Minister Holetschek is only giving part of the overall picture via the previously cited comment. Make no mistake – the unregulated cannabis market will never be 100% diminished in Germany or anywhere else, just as unregulated tobacco products will never go away 100%, and a whole host of other times like fake Rolex watches, moonshine, and other illegal items that are bought and sold around the world every day to some degree will never go away 100%.

Right now, 100% of the adult-use market in Germany goes through unregulated sources given the fact that all adult-use sales are prohibited. Meanwhile, in Canada, a recent study concluded that during the period of 2019-2021, consumers moved from the unregulated market to the regulated market at an increasing rate year over year, with over half of Canadian consumers (55%) now reporting that they obtain their flower exclusively from regulated sources.

Not only does the transition to a regulated market benefit public health directly via the consumption of safer products, it also provides a tremendous boost to local economies and public coffers. As of a year ago, the legal cannabis industry in Canada had reportedly created over 150,000 jobs, generated over $15 billion in taxes and fees for governments of all levels, and contributed over $43.5 billion to the nation’s GDP since the start of legalization. Again, those estimates are from a year ago and obviously have only risen since then. Minister Holetschek can stick to his talking points, however, as you can clearly see the facts are not on his side and policymakers all over the world would benefit from disregarding his opinions when it comes to cannabis policy.

March 2023 Is Set To Be A Historic Month For European Cannabis

The next 32 days on the European continent could prove to be one of the most historic stretches of time for cannabis public policy and the continent’s emerging legal cannabis industry. Starting tomorrow, Malta’s government will begin accepting applications for non-profit cannabis clubs.

It’s a major milestone not just for Malta, which is the only country in Europe to pass a national adult-use legalization measure, but it’s also a major milestone for the greater European industry being that Malta is the first nation in Europe to set up this kind of national adult-use licensing system. It will be very interesting to see how many applications Malta receives next month.

Malta is not the only nation set to experience a historic March 2023. As every global cannabis observer already knows, lawmakers in Germany have worked very hard to make good on their coalition agreement component relating to legalizing cannabis for adult use and implementing a regulated adult-use industry.

Germany’s Health Minister Karl Lauterbach made a formal presentation of a legalization plan back in October 2022 and has since lobbied the European Union for its permission to proceed with an official introduction of a legalization measure.

What some observers seem to have overlooked, or perhaps forgotten about, is that roughly a month ago Minister Lauterbach reportedly confirmed a timetable for a formal introduction of a legalization measure and indicated at the time that he had ‘no reason to doubt’ that a legalization measure would be introduced ‘in the first quarter of this year.’

With February drawing to a close that puts the German adult-use legalization bullseye squarely on the month of March. Whether or not Minister Lauterbach’s reported timeline proves to be accurate or not is something that time will have to determine, although, there have been no meaningful setbacks reported from what I can tell as of the posting of this article.

Additionally, cannabis enthusiasts, entrepreneurs, investors, policymakers, and industry service providers are set to flock to Barcelona, Spain in March as part of the world’s largest super-event collaboration. The International Cannabis Business Conference has once again partnered with Spannabis, Europe’s top cannabis expo, to form another super-event that is a must-attend for anyone that is serious about succeeding in the emerging cannabis industry.

The International Cannabis Business Conference will host Spain’s largest cannabis B2B event on March 9th at the L’Auditori de Cornellà, with the after-party being held at the Hotel Arts (Ritz-Carleton) Barcelona. Spannabis will follow on March 10-12th at Fira de Cornellà. The super-event is the first large cannabis conference collaboration of the year. Whenever thousands of cannabis supporters get together and network good things happen, and that will surely be the case in Barcelona next month.

Cannabis policy and industry in Europe are both at pivotal points, and being that a legal industry cannot come into existence without reform occurring first, the two are directly tied to each other. If Germany does witness the formal introduction of an adult-use legalization measure next month, it will likely set off a wave of similar political activity in other parts of Europe and that will be good news for the continent’s emerging industry.

The same goes for Malta’s cannabis club application rollout. If Malta can successfully gather, review, and approve non-profit cannabis club applications, it will have set up a bureaucratic blueprint for other nations to copy. It’s nuanced but very significant.

We will all have to wait and see what happens for cannabis in Europe in March while doing our best to temper our excitement and expectations.

Malta Home Affairs Ministry Is Reportedly ‘In Talks With A Main Bank’

A unique cannabis public policy and industry experiment is ramping up in Malta where non-profit adult-use cannabis clubs are expected in the near future. Starting next week, Malta’s government will begin accepting applications for non-profit adult-use cannabis clubs. The European nation became just the third country on earth to pass a national adult-use legalization measure in late 2021, with only Uruguay (2013) and Canada (2018) proceeding Malta. Non-profit cannabis clubs will serve as the backbone of Malta’s adult-use industry, and this week the nation’s Home Affairs Ministry reportedly entered into discussions with an unnamed ‘main bank’ that will be needed to help Malta’s emerging industry reach its full potential.

Access to the global banking system has proven to be difficult for certain entities in the public and private sector regarding cannabis commerce, although there are certainly examples of entities being able to successfully navigate the financial regulatory labyrinth in some instances. Still, getting consistent banking solutions pinned down is something that is a top priority for any emerging cannabis market, and Malta is no exception, so reports that there is progress on that front is encouraging.

A Somewhat Unique Model

Cannabis clubs are not a new phenomenon, so from afar, what is going on in Malta may not seem significant. After all, Uruguay and Canada both already permit cannabis clubs to operate in some fashion in certain jurisdictions. For that matter, Barcelona is home to hundreds of private cannabis clubs, albeit operating in a semi-grey area of the law. Yet, Malta is unique compared to those markets in that its entire cannabis commerce model will be based on licensed non-profit cannabis clubs. Home cultivation will be permitted, but the only way to legally purchase cannabis in Malta once clubs are implemented is via non-profit clubs.

It may seem nuanced, but as anyone that has paid attention to the ongoing cannabis banking saga will recognize this is a bit of a new wrinkle. Uruguay has experienced banking issues despite permitting non-profit cannabis clubs, but it also permits sales in pharmacies. That last component was the root of banking issues in Uruguay back in 2017. Major banks in Canada are the subject of a recent lawsuit due to alleged discrimination against cannabis companies. It will be interesting to see if Malta ever experiences the same hurdles given the fact that its legalization model is much more limited compared to Uruguay and Canada.

Helping Create The Blueprint

For many years I blogged about cannabis reform efforts in the United States, and many things have proven to be similar as I have transitioned to blogging about international reform efforts. Similar to different states in the U.S., within the international community there are clearly categories of nations when it comes to cannabis policy. Some are pro-cannabis, some are anti-cannabis, and some are seemingly indifferent. The pro-cannabis nations are doing what they can to get around international hurdles, and anti-cannabis nations are doing everything they can to cling to treaty provisions in an attempt to maintain the prohibition status quo wherever they can.

Due to international treaties, cannabis legalization cannot proceed unhindered in any nation. Even Uruguay and Canada had to consider international agreements and partnerships prior to legalizing, and even when they did proceed, they did so in defiance by some measures. In the Eastern Hemisphere things are proceeding differently. Leaders in nations like Malta and Germany are seeming to be getting more and more creative as they try to figure out a blueprint of sorts for what legalization may look like without violating agreements that extend beyond their borders. With that in mind, the banking discussions in Malta may not seem like a big deal, but if it can add to the previously mentioned metaphorical legalization blueprint in a meaningful way, it will indeed prove to be a very big deal.

Zimbabwe Tobacco Farmers Get More Incentive To Switch To Hemp

Historically, Zimbabwe has served as the top producer of tobacco on the African continent, although in recent years many tobacco farmers in Zimbabwe have transitioned to cultivating hemp due to lowering global demand for tobacco. Zimbabwe’s government more than tripled the amount of allowable THC in hemp this month, and that should further motivate farmers to switch their fields from tobacco to hemp.

Prior to this month, the legal THC threshold for hemp in Zimbabwe was .3%, which is the legal standard in most countries around the world. However, a handful of countries have already raised the threshold from .3% to 1%, and Zimbabwe has followed suit. Zimbabwe joins Australia, Ecuador, Malawi, Switzerland, and Uruguay in setting its hemp THC threshold at 1%.

Why Does It Matter?

Going from a .3% THC threshold to a 1% THC threshold may not seem like a major leap, and yet, it is very significant. Whenever a hemp crop is tested and it has a higher percentage of THC than is allowed by law, the entire crop has to be destroyed. For obvious reasons, that is a very undesirable outcome for any farmer. In Zimbabwe, where the median income is just $932, a failed crop is particularly detrimental.

By allowing farmers in Zimbabwe to cultivate hemp with a higher THC threshold, it accommodates a greater level of THC percentage variance. Farmers that were worried about their current genetics producing slightly too much THC no longer have to worry as much. They now have more cultivars to choose from when deciding what to cultivate, and the medical cannabis products that they produce will be more effective since there will be more THC involved. The cannabinoid ‘entourage effect’ will be enhanced in patients that consume said products thanks to there being more THC in them.

Limited medical cannabis was first legalized in Zimbabwe in 2018, making it only the second country on the African continent to pass such reform. Since that time several other African nations have followed in Zimbabwe’s footsteps and legalized limited medical cannabis production. Will Zimbabwe become the continental leader for hemp, just as it has served historically for tobacco? Only time will tell, but the higher THC threshold will certainly increase the odds of that happening.

Jobs, Economic Boost, And An Improved Environment

Arguably the biggest motivating factor behind Zimbabwe’s recent THC threshold change is economic stimulation. Zimbabwe is one of the poorest nations on earth, and any and all jobs that the hemp industry can create are greatly needed. Demand for hemp products, particularly CBD-based products, is strong worldwide. If Zimbabwe can produce raw hemp to be made into products, and/or produces its own finished products, it will hopefully create many career opportunities in the process.

A booming hemp industry in Zimbabwe wouldn’t just help individuals that work directly in the industry. It would also help create ancillary hemp companies, from security to storage to just about anything else that the mind can imagine. The domestic hemp industry bringing in money from afar via exports would help boost local economies, with hemp industry workers spending their wages in the areas in which they live. Everyone would benefit from an economic butterfly effect from such activity, in addition to the public benefitting directly from increased industry tax and fee revenue.

Cultivating tobacco results in degraded soil and threatened biodiversity. Tobacco farming on a large scale often involves pesticides and fertilizers that are bad for the environment. Conversely, the hemp plant requires very little inputs and actually improves the soil in which it is cultivated via a process known as soil remediation. Furthermore, roughly 4.5 trillion cigarette butts end up in our oceans, rivers, soil, and other places every year, and presumably (hopefully) that will not be the case with hemp products. With all of that in mind, any hectare in Zimbabwe that transitions from tobacco to hemp is a great thing.

A Missed Opportunity In Spain

Yesterday was a potentially big day for cannabis policy reform in Spain, however, a bill that would have set up long-needed medical and adult-use regulations failed to pass in Parliament on Tuesday. For now, the status quo remains.

As we have reported several times in recent months, Spain’s emerging cannabis industry is in desperate need of reform in order to reach its full potential. Reform would, in turn, help consumers and patients across the country.

Unfortunately, that will not happen in the immediate future, although the fight to reform Spain’s cannabis laws is far from over. Still, yesterday’s vote was indeed unfortunate, with blame being warranted towards those that voted in support of prohibition. Per Noticias Sin (translated to English):

A comprehensive legalization of cannabis, both for therapeutic and recreational use , was rejected this Tuesday in the Spanish Parliament.

The socialist party PSOE, which is part of the coalition government in Spain with the left-wing formation United We Can, was one of those who voted against it , along with part of the right-wing opposition.

His partner in the Executive supported the initiative along with other leftist forces or formations such as the liberals of Ciudadanos, in their vote in the Congress or lower house of the Spanish Parliament.

Yesterday’s vote was definitely a missed opportunity, however, cannabis advocates will never give up. Hopefully certain reasonable tweaks can be made to proposed legislation in order to get it to the finish line.

Meanwhile, the unregulated market continues to thrive in Spain. Cannabis laws may not be as bad in Spain as they are in other countries, yet even lukewarm prohibition is still prohibition, and as long as people are being harmed by Spanish prohibition there will always be a need for reform.